Usually not. The FDA first approved extracorporeal shockwave for chronic plantar fasciitis in 2000 and later for tennis elbow, yet most insurers, including Medicare, still classify it as investigational for musculoskeletal conditions and do not pay for it. Coverage lags the evidence, which now includes randomized trials across tendinopathies and calcific tendinitis. What does cover it: HSA and FSA funds, because it is a medical expense for a diagnosed condition, and Cherry financing to spread the cost. Dynamic Athlete accepts Medicare and Kaiser for consultations and office visits. We give a quote after a thorough evaluation. Dynamic Shockwave+ is performed by Aneesh Garg, DO, CAQ, founder of ASTI.
The most common reason people wait on shockwave is the insurance answer. Here is the honest answer, what does pay for it, and the comparison that matters.
First FDA approval for plantar fasciitis: 2000. Shockwave has been an approved treatment for chronic heel pain for over two decades. Most insurers still call it investigational. That gap is the whole story, and why the useful question is not whether it is covered but what it is worth.
The decision
Insurance covers the things it has always covered: the cortisone shot that fades by month three, the physical therapy visits that stall, the imaging, and eventually the surgery. It does not cover the treatment in between. So the decision is not about coverage. It is whether you keep cycling through the covered options or pay once for the one with a different mechanism.
Put the numbers on the same page. A course of shockwave against a year of copays, missed training, and another injection. HSA and FSA funds and Cherry financing exist for exactly this gap. The covered path is not the free path. It is the slow one.
Key takeaways
- Usually not covered. Most insurers and Medicare classify musculoskeletal shockwave as investigational, despite FDA approval for plantar fasciitis in 2000.
- The evidence has moved; the policies have not. Randomized trials and systematic reviews now cover tendinopathies and calcific tendinitis.
- HSA and FSA funds apply, because shockwave for a diagnosed condition is a qualified medical expense, and Cherry financing spreads the cost.
- Consultations are different. Dynamic Athlete accepts Medicare and Kaiser for consultations and office visits.
- Compare a course against the covered cycle, not against zero: cortisone that fades, therapy that stalls, and the months a chronic tendon keeps taking.
- Dynamic Shockwave+ delivers focused ESWT plus EMTT every session, performed by Dr. Aneesh Garg, DO, CAQ, founder of ASTI. Over 90% of our patients self-report a 75% or greater improvement, all without surgery. HSA and FSA funds apply; Cherry financing spreads the cost.
Why insurers say no, and what says yes
The FDA approved it in 2000. Insurers still call it investigational
Extracorporeal shockwave was first approved by the FDA for chronic plantar fasciitis in 2000, and later for chronic lateral epicondylitis. Coverage policy did not follow. Most commercial insurers and Medicare classify musculoskeletal shockwave as investigational and deny it on that basis. The label has outlived the evidence it was written against.
The evidence has moved a long way since the policies were written
A 2015 systematic review of the PEDro database found shockwave effective and safe across a range of orthopedic conditions (Schmitz et al., British Medical Bulletin, 2015). A 2018 review in the Journal of Bone and Joint Surgery summarized its role across tendinopathies, calcific tendinitis, and bone healing (Moya et al., 2018). Randomized multicenter trials exist for plantar fasciitis (Gollwitzer et al., 2015). Policies are reviewed on a schedule; tendons are not.
What does pay for it: HSA, FSA, and financing
Shockwave for a diagnosed condition is a qualified medical expense, so HSA and FSA funds apply. Cherry financing spreads a course over monthly payments. Neither requires a prior authorization or an appeal. For most patients this is how a course is paid for, which is why the insurance answer is less final than it sounds. What drives the cost of a course.
Consultations are a different question
Dynamic Athlete accepts Medicare and Kaiser for consultations and office visits. The evaluation is where the diagnosis is confirmed with exam and diagnostic ultrasound, where focused shockwave is matched to the tissue or ruled out, and where the plan is built. We give a quote after a thorough evaluation and price the plan for optimal outcomes, not line items off a menu.
The comparison that matters: a course against the covered cycle
Insurance pays for the cortisone shot, the physical therapy block, the imaging, and eventually the surgery. It does not pay for the treatment with a different mechanism in between. The honest comparison is a course of focused shockwave against another year of that cycle: copays, an injection that fades by month three, the training and sleep a chronic tendon keeps taking. What six months of waiting adds up to.
Three questions to ask before you pay anyone for shockwave
The bottom line. Insurance covers the slow path. HSA, FSA, and financing cover the direct one. Since you are paying, make sure it is for true focused ESWT, delivered by someone trained to aim and dose it. Ask any clinic these three questions.
- Is this focused ESWT, radial pressure wave, or both, and which does my tissue need?
- Who delivers the session, and where were they trained?
- Is the quote a plan built after an evaluation, or a package off a menu?
Frequently asked questions
Does insurance cover shockwave therapy?
Usually not. Extracorporeal shockwave therapy was first approved by the FDA for chronic plantar fasciitis in 2000 and later for chronic lateral epicondylitis, but most commercial insurers and Medicare still classify it as investigational or not medically necessary for musculoskeletal conditions and deny coverage on that basis. The policies were written years ago and are reviewed on a schedule, while the evidence has continued to accumulate: randomized multicenter trials in plantar fasciitis, systematic reviews across tendinopathies and calcific tendinitis, and a 2018 review in the Journal of Bone and Joint Surgery summarizing its role. Some plans make exceptions for specific diagnoses, and it is worth a call to your insurer, but the working assumption should be that a course of shockwave is paid for directly, with HSA and FSA funds or financing.
Does Medicare cover shockwave therapy?
Generally no for musculoskeletal conditions. Medicare’s coverage position treats extracorporeal shockwave for conditions such as plantar fasciitis and tendinopathy as investigational, so the sessions themselves are not reimbursed. What Medicare does cover at Dynamic Athlete is the consultation and office visit, which is where the diagnosis is confirmed with examination and diagnostic ultrasound and where shockwave is either matched to your tissue or ruled out in favor of something else. Kaiser is accepted for consultations and office visits on the same basis. If a course of Dynamic Shockwave+ is the right plan, it is paid for directly, with HSA or FSA funds if you have them and Cherry financing if spreading the cost helps. We give a quote after a thorough evaluation, never over the phone from a menu.
Can I use my HSA or FSA for shockwave therapy?
Yes. Shockwave therapy prescribed for a diagnosed medical condition such as plantar fasciitis, tendinopathy, or calcific tendinitis is a qualified medical expense, so health savings account and flexible spending account funds can be used to pay for it. No prior authorization, denial letter, or appeal is required; you pay with the account and keep the receipt and the visit documentation, which we provide. Because FSA funds typically expire at the end of the plan year, a course planned in the autumn can use money that would otherwise be lost. For patients without an HSA or FSA, Cherry financing spreads the cost of a course over monthly payments. Between those two options, the insurance answer turns out to be much less final than it sounds on the first phone call.
Why do insurers still call shockwave investigational?
Because coverage policies are written against the evidence available when they were drafted and are updated slowly, while the research has moved quickly. Early shockwave studies in the 1990s and 2000s used different devices, energies, and protocols, and produced mixed results, which is the literature many policies still cite. Since then, randomized multicenter trials with focused devices at defined energies, a 2015 systematic review of the PEDro database that judged shockwave effective and safe across orthopedic conditions, and a 2018 review in the Journal of Bone and Joint Surgery have clarified where it works. Insurers also have a financial incentive to keep an effective outpatient treatment in the investigational category when the alternatives they already cover, such as steroid injections and physical therapy, are cheaper per visit. The label is administrative, not clinical.
What does a course of shockwave cost compared with the covered options?
We give a quote after a thorough evaluation, and we price the plan for optimal outcomes, not line items off a menu, so the honest answer is that the number depends on your tissue and how many sessions it needs. The comparison worth making is not a course against zero. It is a course against what the covered cycle actually costs over a year: the copays for repeated visits, a steroid injection that typically fades by month three, a block of physical therapy that has already stalled, imaging, and the training, work, and sleep a chronic tendon keeps taking from you in the meantime. Insurance pays for that cycle because it is made of things insurers have always paid for, not because it is the better path. HSA and FSA funds and Cherry financing exist for exactly this gap.
Is shockwave worth paying for out of pocket?
That depends on the tissue, and the evaluation answers it before you spend anything. For chronic plantar fasciitis, tendinopathies of the Achilles, patellar, gluteal, and elbow tendons, and calcific tendinitis of the shoulder, focused shockwave has randomized evidence and treats the tissue rather than masking the symptom, so a course can end a cycle that would otherwise repeat every few months. For a problem that shockwave cannot reach, such as a full tendon rupture or a bone-on-bone joint, it is not worth it, and we say so and discuss the right option. The other variable is what you are paying for: true focused ESWT delivered by someone trained to aim and dose it is a different product from a radial session sold under the same word. Dynamic Shockwave+ delivers focused ESWT plus EMTT every session, performed by Dr. Aneesh Garg, DO, CAQ, founder of the American Shockwave Training Institute.
Will Dynamic Athlete bill my insurance for shockwave therapy?
For the consultation and office visit, yes, with Medicare and Kaiser accepted; for the shockwave sessions themselves, no, because insurers do not reimburse them and submitting a claim that will be denied does not help you. What we do instead is straightforward. The evaluation establishes the diagnosis with examination and diagnostic ultrasound and determines whether focused shockwave fits your tissue. If it does, you receive a quote for the plan after that evaluation, priced for optimal outcomes rather than assembled from a menu. You can pay with HSA or FSA funds, use Cherry financing to spread the cost, or pay directly, and we provide the documentation you need for your accounts. Every patient leaves the evaluation with a good understanding of the next steps, whether or not shockwave turns out to be one of them.
Insurance covers the slow path. You can choose the direct one.
Dynamic Shockwave+ delivers focused ESWT plus EMTT every session, performed by Dr. Aneesh Garg, DO, CAQ, founder of ASTI. Consultations accepted with Medicare and Kaiser; HSA, FSA, and Cherry financing for the course.
Book an Evaluation · 1790 30th St, Suite 270, Boulder, CO 80301 · (303) 997-1733